Companies in the life sciences arena face unique challenges: complex domestic and foreign regulations, volatile capital and commercial market trends, and paradigm-shattering scientific advances. Many emerging life sciences clients tend to be growth- and risk-oriented, often with tight cash positions. They require lawyers who are responsive, committed, and focused, as well as value- and solutions-driven. K&L Gates’ life sciences lawyers have a keen sensitivity to these issues. The strength and breadth of the group — across legal practice areas, geographical regions, and life sciences industries — continually expose the lawyers to new information, while the group’s shared commitment enables rapid information dissemination.
K&L Gates’ Life Sciences team is an international network of more than 115 lawyers experienced in solving the complex legal and regulatory issues facing pharmaceutical, biotechnology, health care, and medical device companies around the world. Our team practices in areas as diverse as intellectual property, corporate and securities, regulatory compliance, litigation, employment and executive compensation, environmental, real estate, and tax law. Our life sciences lawyers possess an impressive complement of pharmaceutical, diagnostic, and medical device-related business experience and a deep technical background in molecular and cell biology.
The Life Sciences practice represents a variety of clients, from private equity and venture capital funds, to angel investors, biotechnology start-ups, medical device companies, and academic and research institutions. Our capabilities span the entire spectrum of legal needs of life sciences companies, allowing us to provide integrated advice that result in efficiencies of both cost and precious management time. Our core teams include strategic alliances, licensing, and intellectual property; corporate and transactional; FDA and other regulatory issues; litigation and insurance coverage; and privacy, information management, and data protection.